Seungtea ‘Sam’ Kim
I joined the team in 2021 and I am studying the origins of metastasis. I develop new CRISPR based models of RapidCaP and combine techniques such as whole organ imaging at single cell resolution and single cell sequencing to explore initiation of escape from tumors.